Advances in Complement Inhibitory Strategies for the Treatment of Glomerular Disease: A Rapidly Evolving Field. [PDF]
Conversano E, Vivarelli M.
europepmc +1 more source
Efficacy of Eculizumab in Gemcitabine-Induced Thrombotic Microangiopathy: Experience of the French Thrombotic Microangiopathies Reference Centre [PDF]
Maximilien Grall+9 more
openalex +1 more source
C3 glomerulopathy post kidney transplantation: A single center experience. [PDF]
Zuckerman J+7 more
europepmc +1 more source
The Advancing Landscape of Paroxysmal Nocturnal Hemoglobinuria Treatment [PDF]
Perry C, Von Buttlar X, Thota S.
europepmc +1 more source
A case of renal recovery in atypical hemolytic uremic syndrome treated with eculizumab [PDF]
João Samuel de Holanda Farias+6 more
openalex +1 more source
A Diagnostically Challenging Case of Typical Hemolytic Uremic Syndrome Successfully Treated With Eculizumab Therapy. [PDF]
Jha A, Nader G, Rayamajhi S, Hamdan M.
europepmc +1 more source
The Role of Complement in the Pathogenesis and Treatment of Myasthenia Gravis. [PDF]
Martinez Salazar A+3 more
europepmc +1 more source
Translating biomarker insights into practice: a path forward in TA-TMA management. [PDF]
Jodele S, Gavriilaki E.
europepmc +1 more source